Compare Lead Therapeutics vs MicuRx Pharmaceuticals
Customers evaluate the quality of Lead Therapeutics's products using the following success metrics.
Overview
Lead Therapeutics is 18 yrs old and is based in United States.
LEAD Therapeutics, Inc. is a chemistry-driven drug discovery company focused on delivering novel and differentiated small molecule pre-IND candidates against clinically validated therapeutic targets by leveraging the best of the US and China. Headquartered in the San Francisco Bay Area, LEAD Therapeutics is led by an experienced small molecule drug discovery team with proven track records in the pharmaceutical and biotech industries. The company plans to carry out the majority of its discovery research activities in China.
MicuRx Pharmaceuticals is 17 yrs old and is based in United States.
MicuRx(688373.SH) is a biopharmaceutical company whose mission is to discover and develop antibiotics with improved safety profiles to improve the treatment of resistant bacterial infections. The company was founded in 2007 and is based in Foster City, California.
Demo Video
Leadership
Leonard Post (Founder)
Mike F. Gordeev (Founder, Chief Security Officer, Executive Vice President)
Funding
Investors
Pappas Ventures, ProQuest Investments
Zhongtai Ventures, Founder Hesheng Investment
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Lead Therapeutics has not claimed their profile.
Work for Lead Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Lead Therapeutics?
Claim your profile now.
Information not available because MicuRx Pharmaceuticals has not claimed their profile.
Work for MicuRx Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for MicuRx Pharmaceuticals?
Claim your profile now.
Expert Collections
Game Changers 2018
36 items
Our selected startups are high-momentum companies pioneering technology with the potential to transform society and economies for the better.